Serial SFEMG studies of orbicularis oculi muscle after the first administration of botulinum toxin

European Journal of Neurology

Volumn 6, Issue 4, 1999, Pages 461-467

  Bogucki, Andrzej ^a  

^a Karol Jonscher hospital Lodz   (Poland)

Author keywords

Botulinum toxin; Orbicularis oculi muscle; Reinervation; Single fiber electromyography

Indexed keywords

BOTULINUM TOXIN;

ADULT; AGED; ARTICLE; BLEPHAROSPASM; CELL DENSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRIC POTENTIAL; ELECTROMYOGRAM; FEMALE; HEMIFACIAL SPASM; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INVOLUNTARY MOVEMENT; MALE; MUSCLE REINNERVATION; NEUROMUSCULAR TRANSMISSION; ORBICULARIS OCULI MUSCLE; PRIORITY JOURNAL; REMISSION;

EID: 0032808197     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1999.640461.x     Document Type: Article

References (36)

1. Alderson K, Holds JB, Anderson RL (1991). Botulinuminduced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology 41:1800-1805.
2. American Academy of Neurology (1990). Assessment: the clinical usefulness of botulinum toxin A in treating neurologic disorders. Report of the Therapeutics and Technology Subcommittee of the American Academy of Neurology. Neurology 40:1332-1336.
3. Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, et al. (1993). Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365:160-163.
4. Borodic GE, Ferrante RJ, Pearce LB, Alderson K (1994). Pharmacology and histology of the therapeutic application of botulinum toxin. In: Therapy with botulinum toxin. Jankovic J, Hallet M (editors). New York: Marcel Dekker. pp. 119-157.
5. Bril V, Werb MR, Greene DA, Sima AAF (1996). Single-fiber electromyography in diabetic peripheral polyneuropathy. Muscle Nerve 19:2-9.
6. Duchen LW (1970). Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: differences between fast and slow muscles. J Neurol Neurosurg Psychiatry 33:40-54.
7. Duchen LW, Tonge DA (1977). The effects of implantation of an extra nerve on axonal sprouting usually induced by botulinum toxin in skeletal muscle of the mouse. J Anat 124:205-215.
8. Eleopra R, Tugnoli V, De Grandis D (1997). The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans. Mov Disord 12:89-94.
9. Garner CG, Straube A, Witt TN, Gasser T, Oertel WH (1993). Time course of distant effects of local injections of botulinum toxin. Mov Disord 8:33-37.
10. Giladi N (1995). The non-neuromuscular effects of botulinum toxin injections. Eur J Neurol 2:11-16.
11. Giladi N (1997). The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site. J Neurol Sci 152:132-135.
12. Girlanda P, Vita G, Nicolosi C, Milone S, Messina C (1992). Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psychiatry 55:844-845.
13. Girlanda P, Quartarone A, Sinicropi S, Nicolosi C, Messina C (1996). Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study. Mov Disord 11:27-31.
14. Girlanda P, Quartarone A, Sinicropi S, Nicolosi C, Roberto ML, Picciolo G, et al. (1997). Botulinum toxin in upper limb spasticity: study of reciprocal inhibition between forearm muscles. NeuroReport 8:3039-3044.
15. Glocker FX, Guschlbauer B, Lucking CH, Deutschl G (1995). Effects of local injections of botulinum toxin on electrophysiological parameters in patients with hemifacial spasm: role of synaptic activity and size of motor units. Neurosci Lett 187:161-164.
16. Hesse S, Jahnke MT, Luecke D, Mauritz KH (1995). Short-term electrical stimulation enhances the effectiveness of botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 201:1-4.
17. Holds JB, Alderson K, Fogg SG, Anderson R (1990). Motor nerve sprouting in human orbicularis muscle after botulinum A injection. Invest Ophthalmol Vis Sci 31:964-967.
18. Horn AK, Porter JD, Evinger C (1993). Botulinum toxin paralysis of the orbicularis oculi muscle. Types and time course of alterations in muscle structure, physiology and lid kinematics. Exp Brain Res 96:39-53.
19. Hughes R, Whaler BC (1962). Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Cl. botulinum type A toxin. J Physiol 160:221-233.
20. Jankovic J, Schwartz K, Donovan DT (1990). Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 53:633-639.
21. Juzans P, Comella JX, Molgo J, Faille L, Angauth-Petit D (1996). Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle. Neuromusc Disord 6:177-185.
22. Lange DJ, Brin MF, Warner CL, Lovelace RE, Fahn S (1987). Distant effects of local injection of botulinum toxin. Muscle Nerve 10:552-555.
23. Lange DJ, Brin MF, Fahn S, Lovelace RE (1988). Distant effects of locally injected botulinum toxin: incidence and course. In: Advances in neurology. Vol. 50. Dystonia 2. Fahn S et al. (editors). New York: Raven Press. pp. 609-613.
24. Lange DJ, Rubin M, Greene PE, Kang UJ, Moskowitz CB, Brin MF, et al. (1991). Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve 14:672-675.
25. National Institutes of Health (1991). Consensus Development Conference: clinical use of botulinum toxin. Development statement. Arch Neurol 48:1294-1298.
26. Odergren T, Tollbäck A, Borg J (1994). Electromyographic single motor unit potentials after repeated botulinum toxin treatments in cervical dystonia. Electroenceph Clin Neurophysiol 93:325-329.
27. Oh SJ (1989). The single-fiber EMG in chronic demyelinating neuropathy. Muscle Nerve 12:371-377.
28. Olney RK, Aminoff MJ, Gelb DJ, Lowenstein DH (1988). Neuromuscular effects distant from the site of botulinum neurotoxin injection. Neurology 38:1780-1783.
29. Priori A, Berardelli A, Mercuri B, Manfredi M (1995). Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Brain 118:801-807.
30. Rosales RL, Arimura K, Takenaga S, Osame M (1996). Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 19:488-496.
31. Sanders DB, Stälberg EV (1996). AAEE Minimonograph #25: single-fiber electromyography. Muscle Nerve 19: 1069-1083.
32. Sanders DB, Massey EW, Buckley EG (1986). Botulinum toxin for blepharospasm: single-fiber EMG studies. Neurology 36:545-547.
33. Simpson LL (1989). Peripheral actions of the botulinum neurotoxins. In: Botulinum neurotoxin and tetanus toxin. Simpson LL (editor). San Diego, CA: Academic Press. pp. 153-178.
34. Stälberg E (1990). Use of single fiber EMG and macro EMG in study of reservation. Muscle Nerve 13:804-813.
35. Stälberg E, Trontelj JV (1994). Single fiber electromyography. Studies in healthy and diseased muscle. New York: Raven Press.
36. Stälberg E, Schwartz MS, Trontelj JV (1975). Single fibre electromyography in various processes affecting the antë rior horn cell. J Neurol Sci 38:799-804.